Nondopaminergic therapy of motor and nonmotor symptoms in Parkinson's disease: a clinician's perspective
- PMID: 27599900
- DOI: 10.2217/nmt-2016-0025
Nondopaminergic therapy of motor and nonmotor symptoms in Parkinson's disease: a clinician's perspective
Abstract
Patients with Parkinson's disease suffer from impaired motor behavior due to the dopaminergic striatal deficit and nonmotor symptoms, which also result from nondopaminergic neuronal death. This review provides a personal opinion on treatment strategies for symptoms, resulting at least partially from nondopaminergic neurodegeneration, and on therapeutic modulation of dopaminergic neurotransmission. Patient-tailored treatment regimes on the basis of an individual risk benefit ratio as essential precondition try to balance all these symptoms. Individually varying heterogeneity of symptoms, nonlinear disease progression, treatment response, acceptance, tolerability and safety of applied therapies demand a close, consistent relationship between patient and treating physician. Daily maintenance of patients does not ask for too detailed treatment guidelines.
Keywords: Parkinson's disease; deep brain stimulation; nondopaminergic pharmacotherapy; nonmotor symptoms; repair; repulsive guidance molecule A.
Similar articles
-
Personalized Medicine and Nonmotor Symptoms in Parkinson's Disease.Int Rev Neurobiol. 2017;134:1257-1281. doi: 10.1016/bs.irn.2017.05.015. Int Rev Neurobiol. 2017. PMID: 28805572 Review.
-
New Symptomatic Treatments for the Management of Motor and Nonmotor Symptoms of Parkinson's Disease.Int Rev Neurobiol. 2017;132:407-452. doi: 10.1016/bs.irn.2017.03.004. Epub 2017 May 16. Int Rev Neurobiol. 2017. PMID: 28554417 Review.
-
Nonmotor Parkinson's and Future Directions.Int Rev Neurobiol. 2017;134:1493-1505. doi: 10.1016/bs.irn.2017.05.017. Epub 2017 Jul 4. Int Rev Neurobiol. 2017. PMID: 28805581 Review.
-
The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations.Mov Disord. 2016 Aug;31(8):1080-94. doi: 10.1002/mds.26731. Epub 2016 Jul 19. Mov Disord. 2016. PMID: 27431515 Review.
-
Nonmotor features of Parkinson's disease subtypes.Mov Disord. 2016 Aug;31(8):1095-102. doi: 10.1002/mds.26510. Epub 2016 Feb 10. Mov Disord. 2016. PMID: 26861861 Review.
Cited by
-
Safinamide: an add-on treatment for managing Parkinson's disease.Clin Pharmacol. 2018 Apr 5;10:31-41. doi: 10.2147/CPAA.S137740. eCollection 2018. Clin Pharmacol. 2018. PMID: 29670409 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical